ELDON BIOLOGICALS A/S
CVR 26747007 · Public limited company (A/S) · Active · Low risk
ELDON BIOLOGICALS A/S is a Public limited company (A/S), founded on , based in Gentofte. The company is registered in the industry fremstilling af andre kemiske produkter i.a.n.. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (30 Jun 2025) shows equity of DKK 42.1m and a net result of DKK 3.9m.
Bankruptcy risk for ELDON BIOLOGICALS A/S
0.0 × the average (1.41%) · higher risk than 6% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 26747007
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (24 years)
- Address
- Sandtoften 10
2820 Gentofte - Municipality
- Gentofte
- Industry
- Fremstilling af andre kemiske produkter i.a.n. (205900)
Bankruptcies in the industry: Fremstilling af parfume, hårshampoo, tandpasta mv. - Share capital
- DKK 500k
- Employees
- 9 (2018)
- Auditor
- REVISION SJÆLLAND GODKENDT REVISIONSAKTIESELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 23 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 87.8% |
| Current ratio | 1,159% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 29 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 13.6m | DKK 14.9m |
| Net profit | DKK 3.9m | DKK 6.7m |
| Equity | DKK 42.1m | DKK 40.2m |
| Total assets | DKK 47.9m | DKK 46.7m |
| Cash | DKK 18.4m | – |
| Short-term debt | DKK 3.6m | – |
| Tax owed | DKK 0 | – |
| Avg. employees | 12 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Revision Sjælland Godkendt Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2024 – 30 Jun 2025 | 165 | ||
| 1 Jul 2023 – 30 Jun 2024 | 137 | ||
| 1 Jul 2022 – 30 Jun 2023 | 173 | ||
| 1 Jul 2021 – 30 Jun 2022 | 90 | ||
| 1 Jul 2020 – 30 Jun 2021 | 106 | ||
| 1 Jul 2019 – 30 Jun 2020 | 76 | ||
| 1 Jul 2018 – 30 Jun 2019 | 158 | ||
| 1 Jul 2017 – 30 Jun 2018 | 186 | Late | |
| 1 Jul 2016 – 30 Jun 2017 | 160 | ||
| 1 Jul 2015 – 30 Jun 2016 | 153 | ||
| 1 Jul 2014 – 30 Jun 2015 | 97 | ||
| 1 Jul 2013 – 30 Jun 2014 | 170 | ||
| 1 Jul 2012 – 30 Jun 2013 | 145 | ||
| 1 Jul 2011 – 30 Jun 2012 | 181 | ||
| 1 Jul 2010 – 30 Jun 2011 | 168 | ||
| 1 Jul 2009 – 30 Jun 2010 | 165 | ||
| 1 Jul 2008 – 30 Jun 2009 | 169 | ||
| 1 Jul 2007 – 30 Jun 2008 | 171 | ||
| 1 Jul 2006 – 30 Jun 2007 | 171 | ||
| 1 Jul 2005 – 30 Jun 2006 | 174 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Hans-Ole Hedegaard | ||
| Board | Michael Lützhøft Hansen | Current | |
| Board | Kasper Juul Hedegaard | Current | |
| Board | Cara Beth Seiderman | Current | |
| Board | Hans-Ole Hedegaard | ||
| Board | Hans Josef Wilms | ||
| Owner (33%) | MEDI-TRADE ApS | Current | |
| Owner (50%) | HOLDINGSELSKABET MLH ApS | Current | |
| Owner (10%) | Mads Juul Hedegaard | ||
| Owner (10%) | Nicolai Juul Hedegaard | ||
| Auditor | REVISION SJÆLLAND GODKENDT REVISIONSAKTIESELSKAB | Current | |
| Auditor | Per Sleimann Petersen | ||
| Auditor | V & CO STATSAUTORISERET REVISIONSANPARTSSELSKAB | ||
| Auditor | REVISIONSFIRMAET SLEIMANN ApS | ||
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | ||
| Founder | Michael Lützhøft Hansen | Current | |
| Founder | Hans-Ole Hedegaard | Current |
The CEOs' other companies
Hans-Ole Hedegaard – 6 other companies, of which 1 bankrupt
- ELDONCARD A/S Bankrupt 18 Jul 2002
- Dana Genetic A/S Opløst
- HENOL KEMI ApS, KLÆBESTOFFER OG MASKINER Compulsorily dissolved
- KAPITALFORMIDLINGSSELSKABET AF 12.3.1996 A/S Opløst
- MEDI-TRADE ApS Active
- Pharmagen ApS Active
Address history (0 moves)
| Sandtoften 10, 2820 Gentofte |
Employees per year
Other companies at the same address
- COSMONATION A/S Bankrupt
- ELDONCARD A/S Bankrupt
- NOTOX CORPORATION ApS Bankrupt
- PORTAL HOLDING A/S Bankrupt
- PORTALTJENESTEN A/S Bankrupt
- STOBBE ENGINEERING A/S Bankrupt
- AKSEL BENZIN A/S Active
- AT KO ApS Compulsorily dissolved
- AUTOPACK SOLUTIONS A/S Fusioneret
- BAGFORGOOD APS Active
- BASTION ApS Active
- CW Benzin ApS Fusioneret
- DIGA Engineering ApS Active
- DIGA Holding ApS Active
- E B A M A/S Opløst
- EB LEASING ApS Opløst
- HILLS EQUITY ApS Active
- Homies and Hoodies ApS Active
- Livinsu ApS Active
- Mardexs Danmark ApS Active
- NOTOX A/S Fusioneret
- NOTOX PARTICULATE FILTERS ApS Compulsorily dissolved
- Nifod ApS Active
- Notess.ai ApS Active
- RISHØJ & DE LORENZO ApS Active
Similar companies in Gentofte
- RoscoPharm ApS Gentofte
- Oterra A/S Hellerup
- AQUAMENT HOLDING ApS Hellerup
- LUBRAL NORDIC ApS Hellerup
- DANISH IMPORT-EXPORT ApS Hellerup
Questions and answers about ELDON BIOLOGICALS A/S
Has ELDON BIOLOGICALS A/S gone bankrupt?
No, ELDON BIOLOGICALS A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of ELDON BIOLOGICALS A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the auditor of ELDON BIOLOGICALS A/S?
ELDON BIOLOGICALS A/S most recently used REVISION SJÆLLAND GODKENDT REVISIONSAKTIESELSKAB.
When was ELDON BIOLOGICALS A/S founded?
ELDON BIOLOGICALS A/S was founded on 10 August 2002.
What is the equity of ELDON BIOLOGICALS A/S?
Equity was DKK 42.1m according to the annual report for the period ending 30 June 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.